SUCHILA SOLUTION

I. Do not use if you have any of the following conditions

 
II. Consult a doctor before use if you have any of the following conditions

 
III. Consult a doctor, pharmacist, or pharmacist before use if you have any of the following conditions

(Please see 【Warnings】)

IV. Other Precautions for Use

1. Store properly to prevent accidental ingestion by children.
2. Avoid direct sunlight.
3. Do not exceed the recommended dosage or frequency of use.
4. Wash the application area or surrounding area thoroughly before use.
5. Wash hands thoroughly before and after using this medication.
6. This medication is for external use only and must not be ingested. It should not be used around the eyes or on mucous membranes (such as the mouth, nose, vagina, scrotum, vulva, etc.), ulcers, cracks, or severely injured areas.
7. Please avoid contact with eyes. If contact occurs, immediately rinse with water or warm water and seek immediate medical attention at an ophthalmology clinic.

Do not apply this medication to large areas of the body (approximately the area larger than the user’s two palms). Keep the application area well-ventilated after use; do not seal it to avoid increasing side effects. Do not use on areas other than the affected area, and do not use it as a preventative measure. Do not use this medication continuously for more than 14 days. Keep away from fire. Do not use on large areas for extended periods to avoid salicylic acid poisoning symptoms such as difficulty breathing, sweating, high fever, facial flushing, persistent tinnitus, and severe or persistent headache. Consult a doctor or pharmacist before use. Avoid contact with clothing, plastics, wood, and metal.

 
V. Warnings

1. If any of the following side effects occur after using this medication, please discontinue use immediately and consult a doctor, pharmacist, or pharmacist with this instruction manual:
   • Skin: Erythema, itching, stinging, burning sensation, localized redness, allergic dermatitis
   • Other: Salicylic acid effect (tinnitus, dizziness, nausea, vomiting, etc.)
2. If any of the following symptoms occur after using this medication, please discontinue use immediately and seek medical attention:
   • If any other discomfort occurs besides the above.
   • If your condition does not improve or worsens.

   This medication may cause leukopenia, thrombocytopenia, agranulocytosis, gastrointestinal bleeding, and hematuria. Patients experiencing visual problems after taking this medication should be cautious. Non-steroidal anti-inflammatory drugs (NSAIDs) may affect pregnancy and/or embryonic/fetal development. Use in pregnant women over 30 weeks of gestation may lead to premature closure of the fetal ductus cardiacis and pulmonary hypertension; use in pregnant women over 20 weeks of gestation may lead to fetal renal insufficiency, oligohydramnios, and even neonatal kidney damage; use in early pregnancy may increase the risk of miscarriage and heart malformations. Therefore, please follow these recommendations: Pregnant women over 30 weeks of gestation should avoid using this medication. Pregnant women between 20 and 30 weeks of gestation must consult a physician before use and be treated with the lowest effective dose for the shortest possible duration. If treatment exceeds 48 hours, ultrasound monitoring of amniotic fluid may be necessary. Pregnant women under 20 weeks of gestation and women who may become pregnant should consult a doctor, pharmacist, or pharmacist before use. ul ol